BioInvent International AB (BOVNF)
4.70
0.00 (0.00%)
USD |
OTCM |
Nov 13, 16:00
BioInvent International Shareholders Equity (Quarterly): 99.49M for Sept. 30, 2024
Shareholders Equity (Quarterly) Chart
Historical Shareholders Equity (Quarterly) Data
Date | Value |
---|---|
September 30, 2024 | 99.49M |
June 30, 2024 | 103.41M |
March 31, 2024 | 115.71M |
December 31, 2023 | 130.10M |
September 30, 2023 | 128.84M |
June 30, 2023 | 135.95M |
March 31, 2023 | 151.05M |
December 31, 2022 | 154.10M |
September 30, 2022 | 151.23M |
June 30, 2022 | 143.60M |
March 31, 2022 | 140.68M |
December 31, 2021 | 151.10M |
September 30, 2021 | 164.39M |
June 30, 2021 | 177.05M |
March 31, 2021 | 179.54M |
December 31, 2020 | 90.79M |
September 30, 2020 | 72.92M |
June 30, 2020 | 20.75M |
March 31, 2020 | 13.61M |
December 31, 2019 | 18.13M |
September 30, 2019 | 21.51M |
June 30, 2019 | 26.68M |
March 31, 2019 | 9.667M |
December 31, 2018 | 9.757M |
September 30, 2018 | 13.54M |
Date | Value |
---|---|
June 30, 2018 | 15.78M |
March 31, 2018 | 22.26M |
December 31, 2017 | 15.92M |
September 30, 2017 | 20.13M |
June 30, 2017 | 21.83M |
March 31, 2017 | 23.29M |
December 31, 2016 | 25.42M |
September 30, 2016 | 21.49M |
June 30, 2016 | 25.17M |
March 31, 2016 | 3.657M |
December 31, 2015 | 3.503M |
September 30, 2015 | 6.028M |
June 30, 2015 | 8.88M |
March 31, 2015 | 3.573M |
December 31, 2014 | 6.763M |
September 30, 2014 | 11.18M |
June 30, 2014 | 13.53M |
March 31, 2014 | 4.634M |
December 31, 2013 | 7.644M |
September 30, 2013 | 4.431M |
June 30, 2013 | 3.555M |
March 31, 2013 | 5.120M |
December 31, 2012 | 7.325M |
September 30, 2012 | 10.58M |
June 30, 2012 | 15.11M |
Shareholders' Equity Definition
Shareholder's Equity is a main portion of the balance sheet of a company that measures the net value of a company. The reason for this is because the from an accounting perspective, the balance sheet equation is Shareholder's Equity = Assets - Liabilities. A few examples of shareholder's equity of a company include retained earnings, paid in capital, and preferred stock.
Shareholders Equity (Quarterly) Range, Past 5 Years
13.61M
Minimum
Mar 2020
179.54M
Maximum
Mar 2021
117.12M
Average
133.03M
Median
Shareholders Equity (Quarterly) Benchmarks
Abliva AB | 6.352M |
Oncopeptides AB | 12.22M |
Hansa Biopharma AB | -31.73M |
BioArctic AB | 87.57M |
Camurus AB | 308.68M |
Shareholders Equity (Quarterly) Related Metrics
Total Assets (Quarterly) | 107.86M |
Total Liabilities (Quarterly) | 8.369M |
Current Ratio | 13.29 |